Landscapes / Companies
Fujifilm Pharmaceuticals U.S.A., Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials · 7 in all
Trials
3 active
9 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | May 2029Phase 2 trial completes | |||
| Next date | May 2029 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Biliary Tract Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors, Merkel Cell Carcinoma | ||||
| Open drug page | |||||
About
- No active trial
- Favipiravir, FF-10101-01, FF-10501-01, FF-10502-01, FF21101
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021